Dilution from the Exercise of Stock Options
First written in FY2018. 20 of 25 entries say "Materialised", first in FY2019-Q3. Latest entry: 2026-05-29.
Koryojyuhan moved to the "Worse" side of this theme in 2019, 1 year before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- 2026-05-29MaterialisedShare Issuance and Disposal
「We hereby announce that the terms of issuance of stock acquisition rights to be allotted as stock options to the Company’s executive officers and employees, and to the directors and employees of its subsidiaries, have been finalized today.」
The terms of issuance of the third series of stock acquisition rights were finalized, with 354 rights to be allotted among 255 officers and employees of the Company and its subsidiaries. The event records the finalization of specific issuance terms that may result in future increases in shares outstanding and dilution. - FY2026-H1MaterialisedAnnual report
「1 October 2025–31 March 2026 (Note) 2 6,400 2,781,918 2,368 408,740 2,368 309,940」
During the interim accounting period, 6,400 shares were issued through the exercise of stock acquisition rights, bringing total shares issued to 2,781,918. Dilution from the exercise of stock acquisition rights continues to be realized. - FY2025MitigatedAnnual report
「As of the end of the month preceding the filing date, the number of potential shares attributable to stock acquisition rights was 81,400, equivalent to 2.94% of total shares issued.」
The number of potential shares decreased from 98,200 in the previous fiscal year to 81,400, while the ratio to total shares issued declined from 3.6% to 2.94%. Meanwhile, 17,800 shares were exercised during the fiscal year. - FY2025-H1MaterialisedAnnual report
「1 October 2024–31 March 2025 12,400 2,759,400 4,198 390,387 4,198 291,587 (Note) The increase resulted from the exercise of stock acquisition rights.」
During the interim accounting period, 12,400 shares were issued through the exercise of stock acquisition rights, bringing total shares issued to 2,759,400. Dilution from the exercise of stock acquisition rights continues to be realized. - FY2024MitigatedAnnual report
「As of the end of the month preceding the filing date, the number of potential shares attributable to stock acquisition rights was 98,200, equivalent to 3.6% of total shares issued.」
The number of potential shares decreased from 137,800 in the previous fiscal year to 98,200, while the ratio to total shares issued declined from 5.08% to 3.6%. Meanwhile, the exercise of stock acquisition rights has continued. - FY2024-Q2MaterialisedAnnual report
「1 January 2024–31 March 2024 22,000 2,736,800 9,622 382,361 9,622 283,561 (Note) Increase through the exercise of stock acquisition rights.」
During the second-quarter accounting period, the number of shares increased by 22,000 through the exercise of stock acquisition rights, bringing the total number of issued shares to 2,736,800. The number issued as of the filing date was 2,741,000, but does not include exercises on or after 1 May 2024. - FY2024-Q1MaterialisedAnnual report
「1 October 2023–31 December 2023 3,000 2,714,800 759 372,739 759 273,939 (Note) Increase through the exercise of stock acquisition rights.」
During the first-quarter accounting period, the number of shares increased by 3,000 through the exercise of stock acquisition rights, bringing the total number of issued shares to 2,714,800. Dilution continued to materialise. - FY2023WorsenedAnnual report
「As of the end of the month preceding the filing date, the number of potential shares from stock acquisition rights was 137,800, equivalent to 5.08% of the total number of issued shares.」
Including the unconfirmed balance of the second series of stock acquisition rights, the number of potential shares was 137,800. The absolute number increased from 79,800 in the previous fiscal year. - FY2023-Q3MaterialisedAnnual report
「6,600 shares 2,705,800 1,669 370,462 1,663 271,662 (Note) Increase through the exercise of stock acquisition rights.」
The number of shares increased by 6,600 through the exercise of stock acquisition rights from 1 April 2023 to 30 June 2023, bringing the total number of issued shares after the stock split to 2,705,800. - FY2023-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The number of shares increased by 1,700 through the exercise of stock acquisition rights from 1 January 2023 to 31 March 2023, bringing the total number of issued shares to 1,349,600. - FY2023-Q1MaterialisedAnnual report
「1 October 2022–31 December 2022 1,200 1,347,900 607 367,932 607 269,132 (Note) Increase through the exercise of stock acquisition rights.」
During the first quarter, the number of shares increased by 1,200 through the exercise of stock acquisition rights, bringing the total number of issued shares to 1,347,900. Dilution through the exercise of stock acquisition rights continued to materialise. - FY2022WorsenedAnnual report
「As of the end of the month preceding the filing date, the number of potential shares from stock acquisition rights was 79,800, equivalent to 5.92% of the total number of issued shares.」
While issuance through the exercise of stock acquisition rights continued, 31,700 stock acquisition rights under the second series remained unconfirmed, bringing the number of potential shares to 5.92% of the total number of issued shares. - FY2022-Q3MaterialisedAnnual report
「Common shares 1,345,700 1,346,700」
Against 1,345,700 issued shares at the end of the third-quarter accounting period, the number issued as of the filing date was 1,346,700, and the issuance of shares through the exercise of stock acquisition rights continued to be disclosed. - FY2022-Q2MaterialisedAnnual report
「4,000 1,345,700 2,024 366,819 2,024 268,019 (Note) Increase through the exercise of stock acquisition rights.」
During the second-quarter accounting period, the number of shares increased by 4,000 through the exercise of stock acquisition rights, bringing the total number of issued shares to 1,345,700. In addition, 32,400 common shares were newly established as stock options approved by resolution on 14 January 2022. - FY2022-Q1MaterialisedAnnual report
「1 October 2021–31 December 2021 3,000 1,341,700 1,518 364,795 1,518 265,995 (Note) Increase through the exercise of stock acquisition rights.」
During the first quarter, the number of shares increased by 3,000 through the exercise of stock acquisition rights, bringing the total number of issued shares to 1,341,700. - FY2021MaterialisedAnnual report
「As of the filing date of this document, the number of potential shares from stock acquisition rights was 58,100, equivalent to 4.33% of the total number of issued shares. If these stock acquisition rights are exercised in the future, the value of the Company's shares on a per-share basis may be diluted.」
During the fiscal year, 28,750 stock acquisition rights were exercised, leaving 59,100 unexercised at the end of the period. As of the filing date, the number of potential shares was 58,100, equivalent to 4.33% of the total number of issued shares. - FY2021-Q3MaterialisedAnnual report
「1 April 2021–30 June 2021 11,250 1,333,700 5,692 360,747 5,692 261,947 (Note) Increase through the exercise of stock acquisition rights.」
During the third-quarter accounting period, the number of shares increased by 11,250 through the exercise of stock acquisition rights, bringing the total number of issued shares to 1,333,700. The number issued as of the filing date was disclosed as 1,334,700. - FY2021-Q2MaterialisedAnnual report
「Increase or decrease in total issued shares 8,000 shares (Note) Increase through the exercise of stock acquisition rights.」
During the second-quarter accounting period, the number of shares increased by 8,000 through the exercise of stock acquisition rights, bringing the total number of issued shares to 1,322,450. The number issued as of the filing date was disclosed as 1,331,050. - FY2021-Q1MaterialisedAnnual report
「1 October 2020–31 December 2020 4,500 1,314,450 2,277 351,006 2,277 252,206 (Note) Increase through the exercise of stock acquisition rights.」
During the first quarter, the number of shares increased by 4,500 through the exercise of stock acquisition rights, bringing the total number of issued shares to 1,314,450. The number issued as of the filing date was 1,314,950, with a further 500 shares exercised disclosed. - FY2020MaterialisedAnnual report
「After exercise (shares) End of previous consolidated fiscal year 96,500 Exercised 4,650 Lapsed 3,000 Balance not exercised 88,850」
During the fiscal year, 4,650 stock acquisition rights were exercised, leaving 88,850 unexercised. As of the filing date, the number of potential shares was 87,350, equivalent to 6.66% of the total number of issued shares. - FY2020-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The number of shares increased by 1,000 through the exercise of stock acquisition rights from 1 January 2020 to 31 March 2020, bringing the total number of issued shares to 1,306,450. - FY2020-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The number of shares increased by 150 through the exercise of stock acquisition rights during the quarter, bringing the total number of issued shares to 1,305,450. The number issued as of the filing date was 1,305,950, with a further increase of 500 shares through exercises before the filing date. - FY2019MaterialisedAnnual report
「As of the filing date of this document, the number of potential shares from stock acquisition rights was 95,500, equivalent to 7.30% of the total number of issued shares. If these stock acquisition rights are exercised in the future, the value of the Company's shares on a per-share basis may be diluted.」
During the period, 2,000 stock acquisition rights were exercised, increasing the number of issued shares from 1,303,300 to 1,305,300. The number of potential shares not yet exercised was disclosed as 95,500. - FY2019-Q3MaterialisedAnnual report
「The number of shares issued as of the filing date does not include shares issued through the exercise of stock acquisition rights from 1 August 2019 through the filing date of this quarterly report.」
Against 1,303,300 issued shares at the end of the third-quarter accounting period, the number issued as of the filing date was stated as 1,304,300, with the issuance of shares through the exercise of stock acquisition rights disclosed. - FY2018First statedAnnual report
「As of the filing date of this document, the number of potential shares from stock acquisition rights was 99,000, equivalent to 7.60% of the total number of issued shares. If these stock acquisition rights are exercised in the future, the value of the Company's shares on a per-share basis may be diluted.」
The exercise period runs from 17 May 2019 to 16 May 2027.